ZOCOR

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Netherlands, Poland, Romania, Singapore, South Africa, Spain, UK.

Active ingredients

The drug ZOCOR contains one active pharmaceutical ingredient (API):

1	Simvastatin UNII AGG2FN16EV - SIMVASTATIN
	Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations.
	Read more about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZOCOR Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA01	Simvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2011W, 2012X, 8173E, 9242K, 9243L, 9244M
BR	Câmara de Regulação do Mercado de Medicamentos	525503102110310, 525503103117319, 525503104113317, 525503106116313
CA	Health Products and Food Branch	00884332, 00884340, 00884359
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00990468, 01096835, 03750428, 03751480, 09060601, 17582578
EE	Ravimiamet	1060715, 1080740, 1163023
ES	Centro de información online de medicamentos de la AEMPS	58845, 58846
FI	Lääkealan turvallisuus- ja kehittämiskeskus	382531, 454199
FR	Base de données publique des médicaments	64607301, 67037301
GB	Medicines & Healthcare Products Regulatory Agency	13282, 13283, 13284, 147327, 147329, 182110
HK	Department of Health Drug Office	34336, 34337
IE	Health Products Regulatory Authority	52092, 52183, 52191, 52241, 52268
IT	Agenzia del Farmaco	027216011, 027216023, 027216035, 027216098, 027216100
NL	Z-Index G-Standaard, PRK	67806, 67814, 67822
PL	Rejestru Produktów Leczniczych	100074640, 100074656, 100081260, 100098800
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68124001, W68124002
SG	Health Sciences Authority	03789P, 08893P
US	FDA, National Drug Code	0006-0543, 0006-0735, 0006-0740, 0006-0749
ZA	Health Products Regulatory Authority	31/7.5/0447, W/7.5/350, W/7.5/351